{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,7]],"date-time":"2026-10-07T04:52:14Z","timestamp":1791348734145,"version":"4.3.1"},"reference-count":78,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"1","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2017,2]]},"abstract":"<jats:sec>\n            <jats:title>Purpose of review<\/jats:title>\n            <jats:p>Abdominal obesity is associated with a number of important metabolic abnormalities including liver steatosis, insulin resistance and an atherogenic lipoprotein profile (termed dyslipidemia). The purpose of this review is to highlight recent progress in understanding the pathogenesis of this dyslipidemia.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Recent findings<\/jats:title>\n            <jats:p>Recent results from kinetic studies using stable isotopes indicate that the hypertriglyceridemia associated with abdominal obesity stems from dual mechanisms: (1) enhanced secretion of triglyceride-rich lipoproteins and (2) impaired clearance of these lipoproteins. The over-secretion of large triglyceride-rich VLDLs from the liver is linked to hepatic steatosis and increased visceral adiposity. The impaired clearance of triglyceride-rich lipoproteins is linked to increased levels of apolipoprotein C-III, a key regulator of triglyceride metabolism.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Summary<\/jats:title>\n            <jats:p>Elucidation of the pathogenesis of the atherogenic dyslipidemia in abdominal obesity combined with the development of novel treatments based on apolipoprotein C-III may in the future lead to better prevention, diagnosis and treatment of the atherogenic dyslipidemia in abdominal obesity.<\/jats:p>\n          <\/jats:sec>","DOI":"10.1097\/mol.0000000000000375","type":"journal-article","created":{"date-parts":[[2016,11,24]],"date-time":"2016-11-24T13:39:07Z","timestamp":1479994747000},"page":"11-18","source":"Crossref","is-referenced-by-count":80,"title":["Kinetics of plasma triglycerides in abdominal obesity"],"prefix":"10.1097","volume":"28","author":[{"given":"Elias","family":"Bj\u00f6rnson","sequence":"first","affiliation":[{"name":"Department of Molecular and Clinical Medicine, University of Gothenburg and Sahlgrenska University Hospital, Gothenburg, Sweden"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Martin","family":"Adiels","sequence":"additional","affiliation":[{"name":"Department of Molecular and Clinical Medicine, University of Gothenburg and Sahlgrenska University Hospital, Gothenburg, Sweden"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marja-Riitta","family":"Taskinen","sequence":"additional","affiliation":[{"name":"Research Programs Unit, Diabetes and Obesity, University of Helsinki and Heart and Lung Center, Helsinki University Hospital, Helsinki, Finland"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jan","family":"Bor\u00e9n","sequence":"additional","affiliation":[{"name":"Department of Molecular and Clinical Medicine, University of Gothenburg and Sahlgrenska University Hospital, Gothenburg, Sweden"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","reference":[{"key":"R1-20230917","doi-asserted-by":"crossref","first-page":"1670","DOI":"10.1016\/S0140-6736(10)61350-5","article-title":"Efficacy and safety of more intensive lowering of LDL cholesterol: a meta-analysis of data from 170,000 participants in 26 randomised trials","volume":"376","author":"Cholesterol Treatment Trialists","year":"2010","journal-title":"Lancet"},{"key":"R2-20230917","doi-asserted-by":"crossref","first-page":"1345","DOI":"10.1093\/eurheartj\/ehr112","article-title":"Triglyceride-rich lipoproteins and high-density lipoprotein cholesterol in patients at high risk of cardiovascular disease: evidence and guidance for management","volume":"32","author":"Chapman","year":"2011","journal-title":"Eur Heart J"},{"key":"R3-20230917","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1111\/joim.12071","article-title":"Ectopic lipid storage and insulin resistance: a harmful relationship","volume":"274","author":"Boren","year":"2013","journal-title":"J Intern Med"},{"key":"R4-20230917","doi-asserted-by":"crossref","first-page":"831","DOI":"10.1016\/0092-8674(87)90510-1","article-title":"A novel form of tissue-specific RNA processing produces apolipoprotein-B48 in intestine","volume":"50","author":"Powell","year":"1987","journal-title":"Cell"},{"key":"R5-20230917","doi-asserted-by":"crossref","first-page":"200","DOI":"10.1097\/MOL.0000000000000084","article-title":"Intestinal lipid absorption and lipoprotein formation","volume":"25","author":"Hussain","year":"2014","journal-title":"Curr Opin Lipidol"},{"key":"R6-20230917","doi-asserted-by":"crossref","first-page":"721","DOI":"10.1016\/j.bbalip.2012.01.006","article-title":"Postprandial metabolism of meal triglyceride in humans","volume":"1821","author":"Lambert","year":"2012","journal-title":"Biochim Biophys Acta"},{"key":"R7-20230917","doi-asserted-by":"crossref","first-page":"1538","DOI":"10.1053\/j.gastro.2010.05.002","article-title":"Dynamics of fat absorption and effect of sham feeding on postprandial lipema","volume":"139","author":"Chavez-Jauregui","year":"2010","journal-title":"Gastroenterology"},{"key":"R8-20230917","doi-asserted-by":"crossref","first-page":"761","DOI":"10.1194\/jlr.R051573","article-title":"Circadian regulators of intestinal lipid absorption","volume":"56","author":"Hussain","year":"2015","journal-title":"J Lipid Res"},{"key":"R9-20230917","doi-asserted-by":"crossref","first-page":"G365","DOI":"10.1152\/ajpgi.90591.2008","article-title":"Brief oral stimulation, but especially oral fat exposure, elevates serum triglycerides in humans","volume":"296","author":"Mattes","year":"2009","journal-title":"Am J Physiol Gastrointest Liver Physiol"},{"key":"R10-20230917","doi-asserted-by":"crossref","first-page":"834","DOI":"10.1136\/gut.52.6.834","article-title":"Mobilisation of enterocyte fat stores by oral glucose in humans","volume":"52","author":"Robertson","year":"2003","journal-title":"Gut"},{"key":"R11-20230917","doi-asserted-by":"crossref","first-page":"1702","DOI":"10.1126\/science.1161524","article-title":"A null mutation in human APOC3 confers a favorable plasma lipid profile and apparent cardioprotection","volume":"322","author":"Pollin","year":"2008","journal-title":"Science"},{"key":"R12-20230917","doi-asserted-by":"crossref","first-page":"1123","DOI":"10.1056\/NEJMoa1510926","article-title":"Inactivating variants in ANGPTL4 and risk of coronary artery disease","volume":"374","author":"Dewey","year":"2016","journal-title":"N Engl J Med"},{"key":"R13-20230917","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1007\/s11883-016-0614-1","article-title":"Why is apolipoprotein CIII emerging as a novel therapeutic target to reduce the burden of cardiovascular disease?","volume":"18","author":"Taskinen","year":"2016","journal-title":"Curr Atheroscler Rep"},{"key":"R14-20230917","doi-asserted-by":"crossref","first-page":"513","DOI":"10.1161\/ATVBAHA.110.220723","article-title":"Transcriptional activation of apolipoprotein CIII expression by glucose may contribute to diabetic dyslipidemia","volume":"31","author":"Caron","year":"2011","journal-title":"Arterioscler Thromb Vasc Biol"},{"key":"R15-20230917","doi-asserted-by":"crossref","first-page":"218","DOI":"10.1097\/MOL.0b013e328338cabc","article-title":"Recent insights into factors affecting remnant lipoprotein uptake","volume":"21","author":"Williams","year":"2010","journal-title":"Curr Opin Lipidol"},{"key":"R16-20230917","doi-asserted-by":"crossref","first-page":"222","DOI":"10.1016\/j.atherosclerosis.2012.02.001","article-title":"Postprandial accumulation of chylomicrons and chylomicron remnants is determined by the clearance capacity","volume":"222","author":"Adiels","year":"2012","journal-title":"Atherosclerosis"},{"key":"R17-20230917","doi-asserted-by":"crossref","first-page":"379","DOI":"10.1042\/CS20140559","article-title":"Inter-relationships between proprotein convertase subtilisin\/kexin type 9, apolipoprotein C-III and plasma apolipoprotein B-48 transport in obese subjects: a stable isotope study in the postprandial state","volume":"128","author":"Chan","year":"2015","journal-title":"Clin Sci (Lond)"},{"key":"R18-20230917","doi-asserted-by":"crossref","first-page":"483","DOI":"10.1016\/j.atherosclerosis.2015.01.039","article-title":"New insights into the pathophysiology of dyslipidemia in type 2 diabetes","volume":"239","author":"Taskinen","year":"2015","journal-title":"Atherosclerosis"},{"key":"R19-20230917","doi-asserted-by":"crossref","first-page":"131","DOI":"10.1016\/j.cca.2014.01.015","article-title":"Postprandial hypertriglyceridemia as a coronary risk factor","volume":"431","author":"Boren","year":"2014","journal-title":"Clin Chim Acta"},{"key":"R20-20230917","doi-asserted-by":"crossref","first-page":"2497","DOI":"10.1210\/jc.2014-4348","article-title":"Association of plasma ceramides and sphingomyelin with VLDL apoB-100 fractional catabolic rate before and after rosuvastatin treatment","volume":"100","author":"Ng","year":"2015","journal-title":"J Clin Endocrinol Metab"},{"key":"R21-20230917","doi-asserted-by":"crossref","first-page":"166","DOI":"10.1111\/j.1365-2796.2011.02497.x","article-title":"Kinetic studies to investigate lipoprotein metabolism","volume":"271","author":"Boren","year":"2012","journal-title":"J Intern Med"},{"key":"R22-20230917","doi-asserted-by":"crossref","first-page":"e0138538","DOI":"10.1371\/journal.pone.0138538","article-title":"Improved estimation of human lipoprotein kinetics with mixed effects models","volume":"10","author":"Berglund","year":"2015","journal-title":"PLoS One"},{"key":"R23-20230917","doi-asserted-by":"crossref","first-page":"755","DOI":"10.1007\/s00125-005-0125-z","article-title":"Overproduction of large VLDL particles is driven by increased liver fat content in man","volume":"49","author":"Adiels","year":"2006","journal-title":"Diabetologia"},{"key":"R24-20230917","doi-asserted-by":"crossref","first-page":"1225","DOI":"10.1161\/ATVBAHA.107.160192","article-title":"Overproduction of very low-density lipoproteins is the hallmark of the dyslipidemia in the metabolic syndrome","volume":"28","author":"Adiels","year":"2008","journal-title":"Arterioscler Thromb Vasc Biol"},{"key":"R25-20230917","doi-asserted-by":"crossref","first-page":"463S","DOI":"10.1093\/jn\/129.2.463S","article-title":"Assembly of very low density lipoprotein: a two-step process of apolipoprotein B core lipidation","volume":"129","author":"Rustaeus","year":"1999","journal-title":"J Nutr"},{"key":"R26-20230917","doi-asserted-by":"crossref","first-page":"143","DOI":"10.1093\/bmb\/ldw031","article-title":"Nonalcoholic fatty liver disease in 2016","volume":"119","author":"Townsend","year":"2016","journal-title":"Br Med Bull"},{"key":"R27-20230917","doi-asserted-by":"crossref","first-page":"274","DOI":"10.1111\/j.1365-2036.2011.04724.x","article-title":"Systematic review: the epidemiology and natural history of nonalcoholic fatty liver disease and nonalcoholic steatohepatitis in adults","volume":"34","author":"Vernon","year":"2011","journal-title":"Aliment Pharmacol Ther"},{"key":"R28-20230917","doi-asserted-by":"crossref","first-page":"621","DOI":"10.1038\/nrgastro.2013.197","article-title":"NAFLD-the next global epidemic","volume":"10","author":"Ray","year":"2013","journal-title":"Nat Rev Gastroenterol Hepatol"},{"key":"R29-20230917","doi-asserted-by":"crossref","first-page":"833","DOI":"10.2337\/diab.42.6.833","article-title":"Effects of acute hyperinsulinemia on VLDL triglyceride and VLDL apoB production in normal weight and obese individuals","volume":"42","author":"Lewis","year":"1993","journal-title":"Diabetes"},{"key":"R30-20230917","doi-asserted-by":"crossref","first-page":"779","DOI":"10.2337\/diabetes.47.5.779","article-title":"Effects of insulin and acipimox on VLDL1 and VLDL2 apolipoprotein B production in normal subjects","volume":"47","author":"Malmstrom","year":"1998","journal-title":"Diabetes"},{"key":"R31-20230917","doi-asserted-by":"crossref","first-page":"1454","DOI":"10.1161\/01.ATV.17.7.1454","article-title":"Metabolic basis of hypotriglyceridemic effects of insulin in normal men","volume":"17","author":"Malmstrom","year":"1997","journal-title":"Arterioscler Thromb Vasc Biol"},{"key":"R32-20230917","doi-asserted-by":"crossref","first-page":"2356","DOI":"10.1007\/s00125-007-0790-1","article-title":"Acute suppression of VLDL1 secretion rate by insulin is associated with hepatic fat content and insulin resistance","volume":"50","author":"Adiels","year":"2007","journal-title":"Diabetologia"},{"key":"R33-20230917","doi-asserted-by":"crossref","first-page":"833","DOI":"10.1007\/s00125-015-3856-5","article-title":"Basal and insulin-regulated VLDL1 and VLDL2 kinetics in men with type 2 diabetes","volume":"59","author":"Johansen","year":"2016","journal-title":"Diabetologia"},{"key":"R34-20230917","doi-asserted-by":"crossref","first-page":"1651","DOI":"10.1194\/jlr.R600018-JLR200","article-title":"Thematic review series: patient-oriented research. Recent advances in liver triacylglycerol and fatty acid metabolism using stable isotope labeling techniques","volume":"47","author":"Parks","year":"2006","journal-title":"J Lipid Res"},{"key":"R35-20230917","doi-asserted-by":"crossref","first-page":"1446","DOI":"10.1210\/jc.2005-1709","article-title":"Contributions of different fatty acid sources to very low-density lipoprotein-triacylglycerol in the fasted and fed states","volume":"91","author":"Barrows","year":"2006","journal-title":"J Clin Endocrinol Metab"},{"key":"R36-20230917","doi-asserted-by":"crossref","first-page":"1343","DOI":"10.1172\/JCI23621","article-title":"Sources of fatty acids stored in liver and secreted via lipoproteins in patients with nonalcoholic fatty liver disease","volume":"115","author":"Donnelly","year":"2005","journal-title":"J Clin Invest"},{"key":"R37-20230917","doi-asserted-by":"crossref","first-page":"2562","DOI":"10.1194\/jlr.M600200-JLR200","article-title":"Delayed secretory pathway contributions to VLDL-triglycerides from plasma NEFA, diet, and de novo lipogenesis in humans","volume":"47","author":"Vedala","year":"2006","journal-title":"J Lipid Res"},{"key":"R38-20230917","doi-asserted-by":"crossref","first-page":"1139","DOI":"10.1172\/JCI24930","article-title":"Contribution of adipose tissue and de novo lipogenesis to nonalcoholic fatty liver disease","volume":"115","author":"Tamura","year":"2005","journal-title":"J Clin Invest"},{"key":"R39-20230917","doi-asserted-by":"crossref","first-page":"2433","DOI":"10.2337\/db07-0654","article-title":"The contribution of splanchnic fat to VLDL triglyceride is greater in insulin-resistant than insulin-sensitive men and women: studies in the postprandial state","volume":"56","author":"Hodson","year":"2007","journal-title":"Diabetes"},{"key":"R40-20230917","doi-asserted-by":"crossref","first-page":"1582","DOI":"10.1172\/JCI21047","article-title":"Splanchnic lipolysis in human obesity","volume":"113","author":"Nielsen","year":"2004","journal-title":"J Clin Invest"},{"key":"R41-20230917","first-page":"E431","article-title":"Validation of a new method for determination of free fatty acid turnover","volume":"252","author":"Miles","year":"1987","journal-title":"Am J Physiol"},{"key":"R42-20230917","doi-asserted-by":"crossref","first-page":"2761","DOI":"10.1194\/jlr.M008011","article-title":"Rapid measurement of plasma free fatty acid concentration and isotopic enrichment using LC\/MS","volume":"51","author":"Persson","year":"2010","journal-title":"J Lipid Res"},{"key":"R43-20230917","doi-asserted-by":"crossref","first-page":"1641","DOI":"10.2337\/diabetes.52.7.1641","article-title":"What does the measurement of whole-body fatty acid rate of appearance in plasma by using a fatty acid tracer really mean?","volume":"52","author":"Mittendorfer","year":"2003","journal-title":"Diabetes"},{"key":"R44-20230917","doi-asserted-by":"crossref","first-page":"783","DOI":"10.2337\/db12-0367","article-title":"Kinetics of saturated, monounsaturated, and polyunsaturated fatty acids in humans","volume":"62","author":"Nelson","year":"2013","journal-title":"Diabetes"},{"key":"R45-20230917","doi-asserted-by":"crossref","first-page":"2386","DOI":"10.2337\/db12-1557","article-title":"Systemic free fatty acid disposal into very low-density lipoprotein triglycerides","volume":"62","author":"Koutsari","year":"2013","journal-title":"Diabetes"},{"key":"R46-20230917","doi-asserted-by":"crossref","first-page":"2828","DOI":"10.2337\/db14-1409","article-title":"Adipose tissue free fatty acid storage in vivo: effects of insulin versus niacin as a control for suppression of lipolysis","volume":"64","author":"Ali","year":"2015","journal-title":"Diabetes"},{"key":"R47-20230917","doi-asserted-by":"crossref","first-page":"E1599","DOI":"10.1152\/ajpendo.00015.2012","article-title":"Body composition determines direct FFA storage pattern in overweight women","volume":"302","author":"Sondergaard","year":"2012","journal-title":"Am J Physiol Endocrinol Metab"},{"key":"R48-20230917","doi-asserted-by":"crossref","first-page":"213","DOI":"10.1097\/MOL.0000000000000080","article-title":"Fatty acid sources and their fluxes as they contribute to plasma triglyceride concentrations and fatty liver in humans","volume":"25","author":"Jacome-Sosa","year":"2014","journal-title":"Curr Opin Lipidol"},{"key":"R49-20230917","doi-asserted-by":"crossref","first-page":"1628","DOI":"10.1007\/s00125-009-1405-9","article-title":"Synthesis of specific fatty acids contributes to VLDL-triacylglycerol composition in humans with and without type 2 diabetes","volume":"52","author":"Wilke","year":"2009","journal-title":"Diabetologia"},{"issue":"(Suppl 2)","key":"R50-20230917","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1111\/j.1463-1326.2010.01275.x","article-title":"Hepatic steatosis: a role for de novo lipogenesis and the transcription factor SREBP-1c","volume":"12","author":"Ferre","year":"2010","journal-title":"Diabetes Obes Metab"},{"key":"R51-20230917","doi-asserted-by":"crossref","first-page":"355","DOI":"10.1007\/s00125-014-3422-6","article-title":"Isolated hyperglycaemia does not increase VLDL-triacylglycerol secretion in type 1 diabetic men","volume":"58","author":"Johansen","year":"2015","journal-title":"Diabetologia"},{"key":"R52-20230917","doi-asserted-by":"crossref","first-page":"265","DOI":"10.1172\/JCI108764","article-title":"A possible role for malonyl-CoA in the regulation of hepatic fatty acid oxidation and ketogenesis","volume":"60","author":"McGarry","year":"1977","journal-title":"J Clin Invest"},{"key":"R53-20230917","doi-asserted-by":"crossref","first-page":"1858","DOI":"10.2337\/db16-0236","article-title":"Fasting plasma insulin concentrations are associated with changes in hepatic fatty acid synthesis and partitioning prior to changes in liver fat content in healthy adults","volume":"65","author":"Pramfalk","year":"2016","journal-title":"Diabetes"},{"key":"R54-20230917","doi-asserted-by":"crossref","first-page":"2124","DOI":"10.1194\/jlr.M700600-JLR200","article-title":"Compartmentalization of stearoyl-coenzyme A desaturase 1 activity in HepG2 cells","volume":"49","author":"Yee","year":"2008","journal-title":"J Lipid Res"},{"key":"R55-20230917","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1016\/j.plipres.2012.08.002","article-title":"Stearoyl-CoA desaturase: rogue or innocent bystander?","volume":"52","author":"Hodson","year":"2013","journal-title":"Prog Lipid Res"},{"key":"R56-20230917","doi-asserted-by":"crossref","first-page":"1957","DOI":"10.1002\/hep.23916","article-title":"Type 2 diabetes in mice induces hepatic overexpression of sulfatase 2, a novel factor that suppresses uptake of remnant lipoproteins","volume":"52","author":"Chen","year":"2010","journal-title":"Hepatology"},{"key":"R57-20230917","doi-asserted-by":"crossref","first-page":"1746","DOI":"10.1002\/hep.25580","article-title":"Inhibition of hepatic sulfatase-2 in vivo: a novel strategy to correct diabetic dyslipidemia","volume":"55","author":"Hassing","year":"2012","journal-title":"Hepatology"},{"key":"R58-20230917","doi-asserted-by":"crossref","first-page":"e79473","DOI":"10.1371\/journal.pone.0079473","article-title":"Genetic variation in SULF2 is associated with postprandial clearance of triglyceride-rich remnant particles and triglyceride levels in healthy subjects","volume":"8","author":"Matikainen","year":"2013","journal-title":"PLoS One"},{"key":"R59-20230917","doi-asserted-by":"crossref","first-page":"1309","DOI":"10.1002\/oby.20682","article-title":"SULF2 strongly prediposes to fasting and postprandial triglycerides in patients with obesity and type 2 diabetes mellitus","volume":"22","author":"Hassing","year":"2014","journal-title":"Obesity (Silver Spring)"},{"key":"R60-20230917","doi-asserted-by":"crossref","first-page":"2033","DOI":"10.1016\/S0022-2275(20)35345-1","article-title":"Contribution of apoB-48 and apoB-100 triglyceride-rich lipoproteins (TRL) to postprandial increases in the plasma concentration of TRL triglycerides and retinyl esters","volume":"34","author":"Cohn","year":"1993","journal-title":"J Lipid Res"},{"key":"R61-20230917","doi-asserted-by":"crossref","first-page":"199","DOI":"10.1161\/01.ATV.15.2.199","article-title":"Quantification of postprandial triglyceride-rich lipoproteins in healthy men by retinyl ester labeling and simultaneous measurement of apolipoproteins B-48 and B-100","volume":"15","author":"Karpe","year":"1995","journal-title":"Arterioscler Thromb Vasc Biol"},{"key":"R62-20230917","doi-asserted-by":"crossref","first-page":"2069","DOI":"10.1073\/pnas.90.5.2069","article-title":"Relationships between the responses of triglyceride-rich lipoproteins in blood plasma containing apolipoproteins B-48 and B-100 to a fat-containing meal in normolipidemic humans","volume":"90","author":"Schneeman","year":"1993","journal-title":"Proc Natl Acad Sci U S A"},{"key":"R63-20230917","doi-asserted-by":"crossref","first-page":"2218","DOI":"10.1161\/ATVBAHA.115.305614","article-title":"Kinetic and related determinants of plasma triglyceride concentration in abdominal obesity. Multicenter Tracer Kinetic Study","volume":"35","author":"Bor\u00e9n","year":"2015","journal-title":"Arterioscler Thromb Vasc Biol"},{"key":"R64-20230917","doi-asserted-by":"crossref","first-page":"2144","DOI":"10.1161\/ATVBAHA.111.224808","article-title":"Dual metabolic defects are required to produce hypertriglyceridemia in obese subjects","volume":"31","author":"Taskinen","year":"2011","journal-title":"Arterioscler Thromb Vasc Biol"},{"key":"R65-20230917","doi-asserted-by":"crossref","first-page":"1637","DOI":"10.1210\/jc.2015-3476","article-title":"Impaired insulin suppression of VLDL-triglyceride kinetics in nonalcoholic fatty liver disease","volume":"101","author":"Poulsen","year":"2016","journal-title":"J Clin Endocrinol Metab"},{"key":"R66-20230917","doi-asserted-by":"crossref","first-page":"239","DOI":"10.1161\/ATVBAHA.109.197830","article-title":"Metabolism of very-low-density lipoprotein and low-density lipoprotein containing apolipoprotein C-III and not other small apolipoproteins","volume":"30","author":"Mendivil","year":"2010","journal-title":"Arterioscler Thromb Vasc Biol"},{"key":"R67-20230917","doi-asserted-by":"crossref","first-page":"56","DOI":"10.1097\/MOL.0000000000000146","article-title":"The crucial roles of apolipoproteins E and C-III in apoB lipoprotein metabolism in normolipidemia and hypertriglyceridemia","volume":"26","author":"Sacks","year":"2015","journal-title":"Curr Opin Lipidol"},{"key":"R68-20230917","doi-asserted-by":"crossref","first-page":"1190","DOI":"10.1194\/jlr.P600011-JLR200","article-title":"Rapid turnover of apolipoprotein C-III-containing triglyceride-rich lipoproteins contributing to the formation of LDL subfractions","volume":"48","author":"Zheng","year":"2007","journal-title":"J Lipid Res"},{"key":"R69-20230917","doi-asserted-by":"crossref","first-page":"2855","DOI":"10.1172\/JCI86610","article-title":"ApoC-III inhibits clearance of triglyceride-rich lipoproteins through LDL family receptors","volume":"126","author":"Gordts","year":"2016","journal-title":"J Clin Invest"},{"key":"R70-20230917","doi-asserted-by":"crossref","first-page":"438","DOI":"10.1056\/NEJMoa1400283","article-title":"Antisense inhibition of apolipoprotein C-III in patients with hypertriglyceridemia","volume":"373","author":"Gaudet","year":"2015","journal-title":"N Engl J Med"},{"key":"R71-20230917","doi-asserted-by":"crossref","first-page":"1408","DOI":"10.2337\/dc16-0126","article-title":"Antisense-mediated lowering of plasma apolipoprotein C-III by volanesorsen improves dyslipidemia and insulin sensitivity in Type 2 diabetes","volume":"39","author":"Digenio","year":"2016","journal-title":"Diabetes Care"},{"key":"R72-20230917","doi-asserted-by":"crossref","first-page":"2200","DOI":"10.1056\/NEJMoa1400284","article-title":"Targeting APOC3 in the familial chylomicronemia syndrome","volume":"371","author":"Gaudet","year":"2014","journal-title":"N Engl J Med"},{"key":"R73-20230917","first-page":"797","article-title":"Ex vivo measurement of lipoprotein lipase-dependent very low density lipoprotein (VLDL)-triglyceride hydrolysis in human VLDL: an alternative to the postheparin assay of lipoprotein lipase activity?","volume":"86","author":"Pruneta","year":"2001","journal-title":"J Clin Endocrinol Metab"},{"key":"R74-20230917","doi-asserted-by":"crossref","first-page":"e002258","DOI":"10.1161\/JAHA.115.002258","article-title":"Menopausal status and abdominal obesity are significant determinants of hepatic lipid metabolism in women","volume":"4","author":"Hodson","year":"2015","journal-title":"J Am Heart Assoc"},{"key":"R75-20230917","doi-asserted-by":"crossref","first-page":"730","DOI":"10.1111\/eci.12657","article-title":"Triglyceride-rich lipoprotein metabolism in women: roles of apoC-II and apoC-III","volume":"46","author":"Ooi","year":"2016","journal-title":"Eur J Clin Invest"},{"key":"R76-20230917","doi-asserted-by":"crossref","first-page":"4281","DOI":"10.1210\/jc.2014-2365","article-title":"Interrelationships between the kinetics of VLDL subspecies and HDL catabolism in abdominal obesity: a multicenter tracer kinetic study","volume":"99","author":"Verges","year":"2014","journal-title":"J Clin Endocrinol Metab"},{"key":"R77-20230917","doi-asserted-by":"crossref","first-page":"421","DOI":"10.1016\/S0009-9120(03)00078-X","article-title":"Mechanisms of HDL lowering in insulin resistant, hypertriglyceridemic states: the combined effect of HDL triglyceride enrichment and elevated hepatic lipase activity","volume":"36","author":"Rashid","year":"2003","journal-title":"Clin Biochem"},{"key":"R78-20230917","doi-asserted-by":"crossref","first-page":"2076","DOI":"10.1161\/ATVBAHA.115.306412","article-title":"Hypertriglyceridemia associated with abdominal obesity: getting contributing factors into perspective","volume":"35","author":"Carpentier","year":"2015","journal-title":"Arterioscler Thromb Vasc Biol"}],"container-title":["Current Opinion in Lipidology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.lww.com\/00041433-201702000-00003","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,9,17]],"date-time":"2023-09-17T09:01:13Z","timestamp":1694941273000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.lww.com\/00041433-201702000-00003"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,2]]},"references-count":78,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2017]]}},"URL":"https:\/\/doi.org\/10.1097\/mol.0000000000000375","relation":{},"ISSN":["0957-9672","1473-6535"],"issn-type":[{"value":"0957-9672","type":"print"},{"value":"1473-6535","type":"electronic"}],"subject":[],"published":{"date-parts":[[2017,2]]}}}